RPEP1

Across TCGA pan-cancer cohorts, RPEP1 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RPEP1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RPEP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPEP1 expression acts as an unfavorable survival marker.

UCS, OV, and SKCM are the cancer types where RPEP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	III,IV	0.135	0.590	.048	36	view →
OV	DFS	Tertile	IV	0.244	0.489	.007	18	view →
SKCM	DFS	Tertile	III,IV	0.216	0.606	.003	18	view →
LIHC	OS	Tertile	All	0.156	0.783	.002	18	view →
PRAD	OS	Tertile	All	0.947	0.995	.004	12	view →
BLCA	OS	Tertile	IV	0.288	0.605	.045	9	view →
ACC	DFS	Tertile	All	0.195	0.748	.003	9	view →
ESCA	OS	Median	II,III,IV	0.554	1.000	.021	3	view →
STAD	DFS	Quartile	All	0.572	0.754	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RPEP1–UCS (OS)

Open the UCS breakdown →